These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22824543)
1. Alzheimer disease as a vascular disorder: where do mitochondria fit? Correia SC; Santos RX; Cardoso S; Carvalho C; Candeias E; Duarte AI; Plácido AI; Santos MS; Moreira PI Exp Gerontol; 2012 Nov; 47(11):878-86. PubMed ID: 22824543 [TBL] [Abstract][Full Text] [Related]
2. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652 [TBL] [Abstract][Full Text] [Related]
3. Autophagy in Alzheimer's disease. Moreira PI; Santos RX; Zhu X; Lee HG; Smith MA; Casadesus G; Perry G Expert Rev Neurother; 2010 Jul; 10(7):1209-18. PubMed ID: 20586699 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378 [TBL] [Abstract][Full Text] [Related]
6. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Reddy PH; Beal MF Brain Res Brain Res Rev; 2005 Nov; 49(3):618-32. PubMed ID: 16269322 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: effects of β-amyloid on mitochondria. Tillement L; Lecanu L; Papadopoulos V Mitochondrion; 2011 Jan; 11(1):13-21. PubMed ID: 20817045 [TBL] [Abstract][Full Text] [Related]
8. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease. Pimentel-Coelho PM; Rivest S Eur J Neurosci; 2012 Jun; 35(12):1917-37. PubMed ID: 22708603 [TBL] [Abstract][Full Text] [Related]
9. The dying of the light: mitochondrial failure in Alzheimer's disease. Young-Collier KJ; McArdle M; Bennett JP J Alzheimers Dis; 2012; 28(4):771-81. PubMed ID: 22057028 [TBL] [Abstract][Full Text] [Related]
10. Role of mitochondrial dysfunction in Alzheimer's disease. Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597 [TBL] [Abstract][Full Text] [Related]
11. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Anandatheerthavarada HK; Devi L Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214 [TBL] [Abstract][Full Text] [Related]
14. Role of mitochondrial amyloid-beta in Alzheimer's disease. Chen JX; Yan SS J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403 [TBL] [Abstract][Full Text] [Related]
15. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Swerdlow RH; Khan SM Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin. Moreira PI J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163 [TBL] [Abstract][Full Text] [Related]
17. The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits. Ye X; Tai W; Zhang D Neurobiol Aging; 2012 Jun; 33(6):1122.e1-10. PubMed ID: 22212405 [TBL] [Abstract][Full Text] [Related]
18. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Reddy PH; McWeeney S Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of [Gly14]-Humanin on beta-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction. Jin H; Liu T; Wang WX; Xu JH; Yang PB; Lu HX; Sun QR; Hu HT Neurochem Int; 2010 Feb; 56(3):417-23. PubMed ID: 19941922 [TBL] [Abstract][Full Text] [Related]
20. Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease. Colca JR; Feinstein DL Adv Pharmacol; 2012; 64():155-76. PubMed ID: 22840747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]